|
|
As of 30 June 2022,
- 5,322 confirmed cases of monkeypox from 58 countries globally, 85% in the European Region, 13% in the Region of the Americas, 2% in the Africa Region, <1% in the Eastern Mediterranean Region, and <1% in the Western Pacific Region. One death has been reported in Nigeria.
- 712 confirmed cases from 11 countries and territories in the Americas: Argentina (6 cases), Bahamas (1 case), Brazil (38 cases), Canada (287 cases), Chile (6 cases), Colombia (3 cases), Mexico (15 cases), Peru (3 cases), Puerto Rico (1 case), the United States of America (351 cases), and the Bolivarian Republic of Venezuela (1 case).
- 285 additional confirmed cases and 4 additional country or territory (Bahamas, Colombia, Peru, and Puerto Rico) reporting confirmed cases since the last SitRep on 23 June 2022.
- 92% are reported in men aged 25 to 54 years old, of which most self-identify as men who have sex with other men.
- Increase of cases without history of travel. 40% of cases in the Americas did not report a recent history of travel.
- The first meeting of the International Health Regulation (IHR) Emergency Committee regarding the multi-country outbreak of monkeypox was convened by the WHO Director on 23 June. The committee resolved by consensus to advise the WHO Director-General that at this stage the outbreak should be determined to not constitute a PHEIC. The Committee unanimously acknowledged the emergency nature of the event and that controlling further spread of outbreak requires intense response efforts.
|
